FDA Unveils Plan To Continue Using Remote Inspections

By Luke Zarzecki / September 15, 2025 at 5:33 PM

FDA plans to continue to use remote evaluation tools from the COVID-19 pandemic to evaluate drug manufacturing facilities, including overseas, the agency revealed in new guidance released last week (Sept. 12).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.